Evaluation of prolonged fatigue post-west nile virus infection and association of fatigue with elevated antiviral and proinflammatory cytokines

Viral Immunology

Volumn 27, Issue 7, 2014, Pages 327-333

  Garcia, Melissa N ^a,b   Hause, Anne M ^b   Walker, Christopher M ^b   Orange, Jordan S ^a   Hasbun, Rodrigo ^c   Murray, Kristy O ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE DURATION; FATIGUE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INTERFERON PRODUCTION; MAJOR CLINICAL STUDY; MALE; SYMPTOMATOLOGY; WEST NILE FEVER; WEST NILE FLAVIVIRUS; COHORT ANALYSIS; COMPLICATION; GENETICS; INFORMATION PROCESSING; METABOLISM; MIDDLE AGED; QUESTIONNAIRE; STATISTICAL MODEL;

COHORT STUDIES; CYTOKINES; DATA COLLECTION; FATIGUE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; QUESTIONNAIRES; WEST NILE FEVER;

EID: 84907033125     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2014.0035     Document Type: Article

References (34)

1. Arnett SV, Alleva LM, Korossy-Horwood R, and Clark IA. Chronic fatigue syndrome-a neuroimmunological model. Med Hypotheses 2011;77:77-83.
2. Carson PJ, Konewko P, Wold KS, et al. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis 2006;43:723-730.
3. Centers for Disease Control and Prevention. West Nile Virus disease and other arboviral diseases-United States, 2011. Morbid Mortal Wkly Rep 2012;61:510-514.
4. Centers for Disease Control and Prevention. QuickStats: percentage of adults who often felt very tired or exhausted in the past 3 months, by sex and age group-national health interview survey, United States, 2010. Morbidity and Mortality Weekly Report 2013;62:275.
5. Craig T, and Kakumanu S. Chronic fatigue syndrome: evaluation and treatment.AmFamPhysician 2002;65:1083-1090.
6. Devanur LD, and Kerr JR. Chronic fatigue syndrome. J Clin Virol 2006;37:139-150.
7. Dinarello CA. Proinflammatory cytokines. Chest 2000;118: 503-508.
8. Encabo A, Solves P, Mateu E, et al. Selective generation of different dendritic cell precursors from CD34 + cells by interleukin-6 and interleukin-3. Stem Cells 2004;22:725-740.
9. Finsterer J, and Mahjoub SZ. Fatigue in healthy and diseased individuals. Am J Hosp Palliat Care 2013 Jul 26 [Epub ahead of print].
10. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121:953-959.
11. Gee K, Guzzo C, Che Mat NF, Ma W, and Kumar A. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 2009; 8:40-52.
12. Hamilton JA, and Anderson GP. GM-CSF biology. Growth Factors 2004;22:225-231.
13. Komaroff AL, and Cho TA. Role of infection and neurologic dysfunction in chronic fatigue syndrome. Semin Neurol 2011; 31:325-337.
14. Leis AA, and Stokic DS. Neuromuscular manifestations of west nile virus infection. Front Neurol 2012;3:37.
15. Lindsey NP, Sejvar JJ, Bode AV, Pape WJ, and Campbell GL. Delayed mortality in a cohort of persons hospitalized with West Nile virus disease in Colorado in 2003. Vector Borne Zoonotic Dis 2012;12:230-235.
16. Lorusso L, Mikhaylova SV, Capelli E, et al. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev 2009;8:287-291.
17. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358:261-264.
18. Murray K, Walker C, Herrington E, et al. Persistent infection with West Nile virus years after initial infection. J Infect Dis 2010;201:2-4.
19. Murray KO, Garcia MN, Yan C, and Gorchakov R. Persistence of detectable immunoglobulin m antibodies up to 8 years after infection with West Nile virus. Am J Trop Med Hyg 2013;89:996-1000.
20. Murray KO, Garcia MN, Rahbar MH, Martinez D, Khuwaja SA, Arafat RR, and Rossmann S. Survival analysis, long-term outcomes, and percentage of recovery up to 8 years post-infection among the Houston West Nile virus cohort. PLoS One 2014;9:e102953.
21. Nolan MS, Hause AM, and Murray KO. Findings of longterm depression up to 8 years post infection from West Nile virus. J Clin Psychol 2012;68:801-808.
22. Papa A, Danis K, Athanasiadou A, Delianidou M, and Panagiotopoulos T. Persistence of West Nile virus immunoglobulin M antibodies, Greece. J Med Virol 2011;83: 1857-1860.
23. Patarca R, Klimas NG, Lugtendorf S, Antoni M, and Fletcher MA. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis 1994;18:S147-153.
24. Petersen LR, Carson PJ, Biggerstaff BJ, et al. Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol Infect 2013;141:591-595.
25. Pogodina VV, Frolova MP, Malenko GV, et al. Study on West Nile virus persistence in monkeys. Arch Virol 1983; 75:71-86.
26. Prince HE, Tobler LH, Lape-Nixon M, et al. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J Clin Microbiol 2005;43:4316-4320.
27. Raison CL, Lin JM, and Reeves WC. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav Immun 2009;23: 327-337.
28. Roehrig JT, Nash D, Maldin B, et al. Persistence of virusreactive serum immunoglobulin m antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 2003; 9:376-379.
29. Shirato K, Miyoshi H, Kariwa H, and Takashima I. The kinetics of proinflammatory cytokines in murine peritoneal macrophages infected with envelope protein-glycosylated or non-glycosylated West Nile virus. Virus Res 2006;121: 11-16.
30. Siddharthan V, Wang H, Motter NE, et al. Persistent West Nile virus associated with a neurological sequela in hamsters identified by motor unit number estimation. J Virol 2009;83:4251-4261.
31. Stewart BS, Demarest VL, Wong SJ, Green S, and Bernard KA. Persistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection. BMC Immunol 2011;12:6.
32. The Consortium of Multiple Sclerosis Centers Health Services Research Subcomittee. Multiple Sclerosis Quality of Life Inventory: A User's Manual. New York, NY: National Multiple Sclerosis Society, 1997.
33. Thompson R. Viral hepatitis: mechanism of fatigue in patients with chronic hepatitis C involves carnitine. Nat Rev Gastroenterol Hepatol 2011;8:246.
34. Vernon SD, Whistler T, Aslakson E, Rajeevan M, and Reeves WC. Challenges for molecular profiling of chronic fatigue syndrome. Pharmacogenomics 2006;7: 211-218